Cargando…

Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B Activation and Ameliorates Eye Inflammation in Experimental Autoimmune Uveitis

Bortezomib is a proteasome inhibitor used for hematologic cancer treatment. Since it can suppress NF-κB activation, which is critical for the inflammatory process, bortezomib has been found to possess anti-inflammatory activity. In this study, we evaluated the effect of bortezomib on experimental au...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Sheng-Min, Yang, Chang-Hao, Shen, Fang-Hsiu, Chen, Shun-Hua, Lin, Chia-Jhen, Shieh, Chi-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306382/ https://www.ncbi.nlm.nih.gov/pubmed/25653480 http://dx.doi.org/10.1155/2015/847373

Ejemplares similares

Chitosan Oligosaccharides Suppress Nuclear Factor-Kappa B Activation and Ameliorate Experimental Autoimmune Uveoretinitis in Mice
por: Hsu, Sheng-Min, et al.
Publicado: (2020)

Suppression of the Reactive Oxygen Response Alleviates Experimental Autoimmune Uveitis in Mice
por: Hsu, Sheng-Min, et al.
Publicado: (2020)

Proteasome Inhibitor Bortezomib Ameliorates Intestinal Injury in Mice
por: Yanaba, Koichi, et al.
Publicado: (2012)

Expression of MicroRNAs in the Eyes of Lewis Rats with Experimental Autoimmune Anterior Uveitis
por: Hsu, Yung-Ray, et al.
Publicado: (2015)

MicroRNA-146a Alleviates Experimental Autoimmune Anterior Uveitis in the Eyes of Lewis Rats
por: Hsu, Yung-Ray, et al.
Publicado: (2017)

Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure()
por: Pitcher, David S., et al.
Publicado: (2015)

The resistance mechanisms of proteasome inhibitor bortezomib
por: Lü, Shuqing, et al.
Publicado: (2013)

Amelioration of Experimental Autoimmune Uveitis by Leflunomide in Lewis Rats
por: Fang, Cheng-bo, et al.
Publicado: (2013)

Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
por: Miraghazadeh, Bahar, et al.
Publicado: (2018)

Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity
por: Lee, Jin Hee, et al.
Publicado: (2018)

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
por: Alexander, Tobias, et al.
Publicado: (2015)

Ameliorating effects of bortezomib, a proteasome inhibitor, on development of dextran sulfate sodium-induced murine colitis
por: Sakai, Shigeki, et al.
Publicado: (2018)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-β1
por: Zeniya, Moko, et al.
Publicado: (2017)

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
por: Boccadoro, Mario, et al.
Publicado: (2005)

Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
por: Gelman, Julia S., et al.
Publicado: (2013)

Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors
por: Tran, Huy Minh, et al.
Publicado: (2020)

ATRT-01. UPREGULATION OF PROTEIN SYNTHESIS AND PROTEASOME DEGRADATION CONFERS SENSITIVITY TO PROTEASOME INHIBITOR BORTEZOMIB IN MYC-ATYPICAL TERATOID/RHABDOID TUMORS
por: Tran, Minh-Huy, et al.
Publicado: (2020)

Periploca forrestii saponin ameliorates CIA via suppressing proinflammatory cytokines and nuclear factor kappa-B pathways
por: Bao, Chunmei, et al.
Publicado: (2017)

The Protective Effects of the Proteasome Inhibitor Bortezomib (Velcade) on Ischemia-Reperfusion Injury in the Rat Retina
por: Chen, Fang-Ting, et al.
Publicado: (2013)

Inhibiting TLR7 Expression in the Retinal Pigment Epithelium Suppresses Experimental Autoimmune Uveitis
por: Lo, Sheng-Min, et al.
Publicado: (2022)

Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis
por: Kang, Minkyung, et al.
Publicado: (2020)

The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes
por: Mondanelli, Giada, et al.
Publicado: (2017)

Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib
por: Steverding, Dietmar, et al.
Publicado: (2009)

Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib
por: Schlesser, Camille, et al.
Publicado: (2022)

Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
por: Chen, Yun-Ju, et al.
Publicado: (2013)

Microbiome and Autoimmune Uveitis
por: Horai, Reiko, et al.
Publicado: (2019)

The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
por: Giuliani, Cesidio, et al.
Publicado: (2018)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Pasquale, Raffaella, et al.
Publicado: (2021)

Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice
por: Li, He, et al.
Publicado: (2021)

Proteasome inhibition by bortezomib: A left hook and a right punch
por: Roelofs, Jeroen
Publicado: (2015)

Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting
por: Penna, Fabio, et al.
Publicado: (2015)

Bortezomib-resistance is associated with increased levels of proteasome subunits and apoptosis-avoidance
por: Wu, Yi-Xin, et al.
Publicado: (2016)

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
por: Yang, David T, et al.
Publicado: (2008)

Experimental autoimmune uveitis and other animal models of uveitis: An update
por: Bansal, Svati, et al.
Publicado: (2015)

Immunotherapeutic strategies in autoimmune uveitis
por: Papotto, Pedro Henrique, et al.
Publicado: (2014)

Autoimmune and autoinflammatory mechanisms in uveitis
por: Lee, Richard W., et al.
Publicado: (2014)

Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial
por: Astakhova, Tatiana M., et al.
Publicado: (2018)

Role of nuclear factor-kappa B in feline injection site sarcoma
por: Hsueh, Cheng-Shun, et al.
Publicado: (2019)

Integrated Transcriptome Analysis of Iris Tissues in Experimental Autoimmune Uveitis
por: Li, Dan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5b5nfch535bjf5r11fsgrmnccc